Recently, studies identified rapamycin-mediated inhibition of PHLPP (PH domain leucine-rich repeats protein phosphatase) expression through a mTOR-dependent compensatory feedback loop may contribute to rapamycin resistance in colon cancer cells [17]. Here, MTOR is linked to malignant colon neoplasm.